Charmacy Pharmaceutical Co., Ltd.
HKEX:2289.HK
8.35 (HKD) • At close September 16, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 634.197 | 492.674 | 630.168 | 590.322 | 506.308 | 428.601 | 75.097 | 477.306 | 155.629 | 22.296 | 16.761 |
| Short Term Investments
| 10.559 | 11.133 | 11.588 | 11.699 | 11.218 | 11.002 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 634.197 | 503.807 | 641.756 | 602.021 | 517.527 | 439.604 | 75.097 | 477.306 | 155.629 | 22.296 | 16.761 |
| Net Receivables
| 965.352 | 865.255 | 731.26 | 763.994 | 734.514 | 827.973 | 970.254 | 930.325 | 975.058 | 795.601 | 657.808 |
| Inventory
| 775.842 | 586.854 | 509.156 | 585.009 | 515.162 | 472.523 | 431.592 | 351.523 | 318.465 | 244.935 | 256.746 |
| Other Current Assets
| 436.609 | 506.445 | 356.05 | 300.285 | 251.501 | 221.984 | 626.298 | 122.515 | 398.961 | 274.14 | 308.684 |
| Total Current Assets
| 2,812 | 2,462.361 | 2,238.222 | 2,251.309 | 2,018.704 | 1,962.084 | 2,103.242 | 1,881.669 | 1,848.113 | 1,336.972 | 1,239.999 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 328.548 | 294.08 | 348.436 | 372.5 | 317.365 | 217.55 | 197.272 | 117.683 | 117.667 | 124.606 | 130.798 |
| Goodwill
| 6.024 | 6.024 | 6.024 | 6.024 | 3.128 | 3.128 | 4.594 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 76.723 | 80.857 | 143.034 | 152.192 | 153.081 | 159.338 | 160.724 | 109.095 | 96.35 | 71.251 | 73.466 |
| Goodwill and Intangible Assets
| 82.747 | 86.881 | 149.058 | 158.216 | 156.209 | 162.466 | 165.317 | 109.095 | 96.35 | 71.251 | 73.466 |
| Long Term Investments
| 0 | 374.737 | 489.334 | 521.423 | 467.547 | 374.381 | 357.866 | 226.206 | 213.177 | 194.75 | 0 |
| Tax Assets
| 7.383 | 6.224 | 8.16 | 9.293 | 6.027 | 5.636 | 4.723 | 0.573 | 0.84 | 1.107 | 0 |
| Other Non-Current Assets
| 16.979 | -380.961 | -497.494 | -530.716 | -473.574 | -380.016 | -362.589 | -226.779 | -214.017 | -195.857 | 0.339 |
| Total Non-Current Assets
| 435.656 | 380.961 | 497.494 | 530.716 | 473.574 | 380.016 | 362.589 | 226.779 | 214.017 | 195.857 | 204.603 |
| Total Assets
| 3,247.656 | 2,865.885 | 2,763.092 | 2,799.403 | 2,503.808 | 2,353.98 | 2,471.83 | 2,111.57 | 2,062.97 | 1,533.936 | 1,444.602 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 659.074 | 876.776 | 809.768 | 938.611 | 833.561 | 778.925 | 928.825 | 779.805 | 1,292.063 | 930.461 | 873.42 |
| Short Term Debt
| 1,531.069 | 1,390.027 | 1,512.566 | 1,509.051 | 1,364.915 | 1,166.825 | 522.9 | 421.362 | 290.65 | 301.35 | 299.56 |
| Tax Payables
| 55.95 | 94.156 | 44.558 | 58.549 | 48.989 | 37.441 | 50.867 | 4.164 | 2.433 | 5.458 | 0 |
| Deferred Revenue
| 426.181 | -1,390.027 | -1,512.566 | -1,509.051 | -1,364.915 | -1,166.825 | -522.9 | -421.362 | -290.65 | -301.35 | 0 |
| Other Current Liabilities
| 2.534 | 1,378.812 | 1,349.156 | 1,223.383 | 1,044.698 | 1,006.897 | 1,077.985 | 888.995 | 356.651 | 357.91 | 62.502 |
| Total Current Liabilities
| 2,618.858 | 2,255.588 | 2,158.925 | 2,161.994 | 1,878.259 | 1,785.823 | 2,006.81 | 1,668.801 | 1,648.714 | 1,288.371 | 1,235.482 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 30.39 | 15.755 | 86.867 | 118.456 | 126.353 | 90 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| -0.601 | 0 | 0.305 | 0.762 | 1.219 | 1.219 | 1.613 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0.601 | 0.06 | 0.403 | 0.311 | 125.134 | 0.201 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.601 | 0 | -0.708 | -1.073 | -126.353 | -1.419 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 30.991 | 15.815 | 86.867 | 118.456 | 126.353 | 90 | 1.613 | 0 | 0 | 0 | 0 |
| Total Liabilities
| 2,649.849 | 2,271.403 | 2,258.99 | 2,296.854 | 2,020.215 | 1,877.242 | 2,008.423 | 1,668.801 | 1,648.714 | 1,288.371 | 1,235.482 |
| Equity: | |||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 108 | 108 | 108 | 108 | 108 | 108 | 108 | 108 | 108 | 80 | 80 |
| Retained Earnings
| 181.155 | 207.491 | 117.111 | 115.558 | 96.602 | 89.747 | 65.914 | 53.554 | 6.274 | 108.445 | 72 |
| Accumulated Other Comprehensive Income/Loss
| 278.991 | 0.989 | 0.989 | 0.989 | 0.989 | 0.989 | 0.989 | 0 | 139.65 | 57.12 | 57.12 |
| Other Total Stockholders Equity
| 29.661 | 278.002 | 278.002 | 278.002 | 278.002 | 278.002 | 281.216 | 281.216 | 160.332 | 0 | 0 |
| Total Shareholders Equity
| 597.807 | 594.482 | 504.102 | 502.549 | 483.593 | 476.737 | 456.118 | 442.769 | 414.256 | 245.565 | 209.12 |
| Total Equity
| 597.807 | 594.482 | 504.102 | 502.549 | 483.593 | 476.737 | 463.407 | 442.769 | 414.256 | 245.565 | 209.12 |
| Total Liabilities & Shareholders Equity
| 3,247.656 | 2,865.885 | 2,763.092 | 2,799.403 | 2,503.808 | 2,353.98 | 2,471.83 | 2,230.793 | 2,062.97 | 1,533.936 | 1,444.602 |